Development of a Measure to Assess Attitudes Towards Nasal versus Autoinjector Glucagon Delivery Devices for Treatment of Severe Hypoglycemia.

Bajpai, Sanjay K; Cambron-Mellott, M Janelle; Will, Oliver; Poon, Jiat-Ling; Wang, Qianqian; Mitchell, Beth D; Peck, Eugenia Y; Babrowicz, Jane; Raibulet, Nedina K; Child, Christopher J; Beusterien, Kathleen

Bajpai, Sanjay K; Cambron-Mellott, M Janelle; Will, Oliver; Poon, Jiat-Ling; Wang, Qianqian; Mitchell, Beth D; Peck, Eugenia Y; Babrowicz, Jane; Raibulet, Nedina K; Child, Christopher J; Beusterien, Kathleen.

Afiliación

Bajpai SK; Eli Lilly and Company, Indianapolis, IN, USA.
Cambron-Mellott MJ; Cerner Enviza, New York, NY, USA.
Will O; Cerner Enviza, New York, NY, USA.
Poon JL; Eli Lilly and Company, Indianapolis, IN, USA.
Wang Q; Eli Lilly and Company, Indianapolis, IN, USA.
Mitchell BD; Eli Lilly and Company, Indianapolis, IN, USA.
Peck EY; Cerner Enviza, New York, NY, USA.
Babrowicz J; Cerner Enviza, New York, NY, USA.
Raibulet NK; Eli Lilly and Company, Indianapolis, IN, USA.
Child CJ; Eli Lilly and Company, Indianapolis, IN, USA.
Beusterien K; Cerner Enviza, New York, NY, USA.

Diabetes Metab Syndr Obes ; 15: 3601-3615, 2022.

Article en En | MEDLINE | ID: mdl-36439296

Palabras clave

diabetes; glucagon delivery device; patient attitudes; severe hypoglycemic events

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Qualitative_research Idioma: En Revista: Diabetes Metab Syndr Obes Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google